UnitedHealth Faces Reset After 0.09% Medicare Advantage Rate Proposal as Analyst Targets Diverge
The near-zero 2027 Medicare Advantage update has become the key overhang for the biggest private Medicare carrier.
Overview
- CMS proposed a 0.09% Medicare Advantage rate increase for 2027, far below the 4%–6% many expected, prompting a broad sector repricing.
- UnitedHealth’s 2026 revenue outlook came in below Wall Street forecasts, and management plans to prioritize margins over membership with a projected revenue dip to about $439 billion.
- Wells Fargo cut its price target to $370 and kept an Overweight rating, TD Cowen lowered its target to $311 with a Hold, and Bernstein reiterated an Outperform at $405.
- Wells Fargo flagged disappointing Medicare Advantage economics, concerning Optum Health results, and limited visibility into 2026 for that segment, and trimmed estimates into 2027.
- Shares have fallen sharply over the past year and now trade near a 15x forward P/E, sharpening focus on valuation and the path to earnings recovery.